St. Jude Children’s Research Hospital scientists, in collaboration with the Institute of Environmental Science and Research (ESR) Limited, found that immune cells present in people months before influenza (flu) infection could more accurately predict if an individual would develop symptoms than current methods which primarily rely on antibody levels.
FDA rejects Eli Lilly’s eczema drug due to third-party manufacturing issues
FDA has rejected Eli Lilly’s eczema treatment lebrikizumab due to issues found at an unnamed third-party manufacturer. According to a press release, a “multi-sponsor” inspection
October 3, 2023